| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.02 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.17 | 0.02 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |